# EDGAR Filing Document

**Accession Number:** 0001837254
**File Stem:** 0001213900-26-060152
**Filing Date:** 2026-5
**Character Count:** 4172
**Document Hash:** 0842b9cdc07776cabc502c85fd0a45d6
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-060152.hdr.sgml**: 20260521

**ACCESSION NUMBER**: 0001213900-26-060152

**CONFORMED SUBMISSION TYPE**: DEFA14A

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260521

**DATE AS OF CHANGE**: 20260521

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Functional Brands Inc.
- **CENTRAL INDEX KEY:** 0001837254
- **STANDARD INDUSTRIAL CLASSIFICATION:** MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 854094332
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** DEFA14A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42936
- **FILM NUMBER:** 261009896

**BUSINESS ADDRESS:**
- **STREET 1:** 8605 SANTA MONICA BLVD
- **CITY:** WEST HOLLYWOOD
- **STATE:** CA
- **ZIP:** 90069
- **BUSINESS PHONE:** 7789383367

**MAIL ADDRESS:**
- **STREET 1:** 8605 SANTA MONICA BLVD
- **CITY:** WEST HOLLYWOOD
- **STATE:** CA
- **ZIP:** 90069

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HT Naturals Corp.
- **DATE OF NAME CHANGE:** 20201218

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**SCHEDULE 14A**

**(Rule 14a-101)**

**INFORMATION REQUIRED IN PROXY STATEMENT**

**SCHEDULE 14A INFORMATION**

**Proxy Statement Pursuant to Section 14(a) of the Securities**

**Exchange Act of 1934**

Filed by the Registrant ☑ <br> Filed by a Party other than the Registrant ☐

Check the appropriate box:

☐ Preliminary Proxy Statement

**☐** **Confidential, for Use of the Commission only (as permitted by Rule 14a-6(e)(2))**

☐ Definitive Proxy Statement

☑ Definitive Additional Materials

☐ Soliciting Material Pursuant to §240.14a-12

**FUNCTIONAL BRANDS INC.**

(Name of Registrant as Specified in Its Charter)

(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

Payment of Filing Fee (Check the appropriate box):

☑ No fee required. <br> ☐ Fee paid previously with preliminary materials: <br> ☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a–6(i)(1) and 0–11

**Explanatory Note**

On May 21, 2026, Functional Brands, Inc. issued the following letter to certain stockholders of record in respect of its upcoming Special Meeting of stockholders.

**Special Meeting Letter**

May 21, 2026

Shareholder name/address

I am David Wells, Chief Financial Officer, of Functional Brands Inc. Functional Brands has scheduled a special meeting of shareholders for Thursday, May 28, 2026, and we are reaching out because our immediate objective is to secure shareholder participation and proxy support to hold the meeting as planned.

We are unable to locate a telephone number for you; therefore, would welcome the opportunity to speak with you at your earliest convenience regarding ownership of a sizable number of Functional Brands shares. Because every vote matters, I would welcome the opportunity to speak with you directly, answer any questions you may have, and help ensure your proxy is submitted in time. Even if you sold your shares, you are still entitled to vote since you were a shareholder of record on April 16, 2026.

Our purpose in contacting you is straightforward: we are working to obtain the shareholder support needed to move this process forward and avoid any delay or adjournment of the special meeting. Your proxy vote is therefore very important, and your prompt response will directly assist the Company in closing the gap toward the amount needed to proceed.

To make voting as easy as possible, we have established a toll-free number for shareholders to vote: 877-672-7073. A representative at the Call Center would be pleased to take your voting instructions by telephone and provide confirmation, and we strongly encourage you to submit your proxy as soon as possible. You can also call our proxy solicitor, Donna Ackerly of Lioness Consulting LLC, at 609-651-2267 or via email: dackerly@lionessconsultingllc.com.

Thank you for your time and prompt attention to this matter.

Sincerely,

![](ea029190701_img1.jpg)

David R. Wells

Chief Financial Officer

Mobile: 310-936-3128

Email: drwells@davidrwells.com